Hepatitis C (eBook)
493 Seiten
Elsevier Science (Verlag)
978-0-08-053391-9 (ISBN)
The editors, T. Jake Liang, M.D., and Jay H. Hoofnagle, M.D., are both hepatologists and clinical and laboratory researchers who are well known leaders in the hepatitis field. Their team of authors provide the latest information on key issues such as the role of hepatitis C in liver cancer and evolving therapy for hepatitis C, including special subgroups of patients such as children, patients with renal failure, patients undergoing liver transplantation, and patients with HIV coinfection. The book also addresses future directions in antiviral therapy of hepatitis C and the real challenges of developing a vaccine. Hepatitis C is the integrated reference book for all researchers, clinicians, and students dealing with this troubling virus.
Key Features
* Provides comprehensive coverage of hepatitis C, ranging from basic science to clinical application
* Includes contributions from more than 30 international experts in the field
* Supplies current recommendations on management of hepatitis C
* Designed in an easy-to-use format with consistent organization
* Includes extensive illustrations
The anticipated encore volume of the Biomedical Research Reports Series, Hepatitis C is the first book that offers comprehensive and up-to-date coverage of this "e;silent epidemic."e; The subject matter ranges from basic science to clinical medicine, with contributions from more than 30 international experts in the field. This important new book details the hepatitis C virus and the disease that it causes, including its prevalence, means of spread, symptoms, complications, natural history, prevention, and therapy.The editors, T. Jake Liang, M.D., and Jay H. Hoofnagle, M.D., are both hepatologists and clinical and laboratory researchers who are well known leaders in the hepatitis field. Their team of authors provide the latest information on key issues such as the role of hepatitis C in liver cancer and evolving therapy for hepatitis C, including special subgroups of patients such as children, patients with renal failure, patients undergoing liver transplantation, and patients with HIV coinfection. The book also addresses future directions in antiviral therapy of hepatitis C and the real challenges of developing a vaccine. Hepatitis C is the integrated reference book for all researchers, clinicians, and students dealing with this troubling virus.Key Features* Provides comprehensive coverage of hepatitis C, ranging from basic science to clinical application* Includes contributions from more than 30 international experts in the field* Supplies current recommendations on management of hepatitis C* Designed in an easy-to-use format with consistent organization* Includes extensive illustrations
Front Cover 1
Hepatitis C: Biomedical Research Reports 4
Copyright Page 5
Contents 8
Chapter 1. Molecular Biology of Hepatitis C Virus 24
Chapter 2. Hepatitis C: Viral Markers and Quasispecies 48
Chapter 3. Hepatitis C Virus Genotypes 76
Chapter 4. Acute Hepatitis C 94
Chapter 5. Natural History of Hepatitis C 108
Chapter 6. Pathology of Hepatitis C 130
Chapter 7. Humoral Response to Hepatitis C Virus 148
Chapter 8. Immunopathogenesis of Hepatitis C 170
Chapter 9. Epidemiology of Hepatitis C 192
Chapter 10. Worldwide Prevalence and Prevention of Hepatitis C 208
Chapter 11. Therapy of Chronic Hepatitis C 226
Chapter 12. Hepatitis C and Cirrhosis 264
Chapter 13. Hepatitis C and Hepatocellular Carcinoma 288
Chapter 14. Hepatitis C and Liver Transplantation 300
Chapter 15. Mixed Cryoglobulinemia and Other Extrahepatic Manifestations of Hepatitis C Virus Infection 318
Chapter 16. Hepatitis C Virus and Human Immunodeficiency Virus Coinfection 338
Chapter 17. Hepatitis C and Renal Disease 352
Chapter 18. Chronic Hepatitis C and Porphyria Cutanea Tarda 374
Chapter 19. Hepatitis C Virus Infection and Alcohol 386
Chapter 20. Hepatitis C in Children 412
Chapter 21. Hepatitis C and Pregnancy 428
Chapter 22. Hepatitis C and Iron 438
Chapter 23. Complementary and Alternative Medicine in Hepatitis C 450
Chapter 24. Development of Novel Therapies for Hepatitis C 476
Chapter 25. Hepatitis C Vaccines 492
Index 510
Color Plate Section 518
Erscheint lt. Verlag | 9.10.2000 |
---|---|
Mitarbeit |
Herausgeber (Serie): Anthony S. Fauci, John I. Gallin |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
Medizinische Fachgebiete ► Innere Medizin ► Hepatologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin | |
Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
Naturwissenschaften ► Biologie | |
Technik | |
ISBN-10 | 0-08-053391-4 / 0080533914 |
ISBN-13 | 978-0-08-053391-9 / 9780080533919 |
Haben Sie eine Frage zum Produkt? |
![PDF](/img/icon_pdf_big.jpg)
Größe: 38,1 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich